Tuesday, 22 November 2016
Ava bags $10million for wrist-worn facility tracker
Ava, which focuses on women’s reproductive health, reeled in a $9.7 million Series A funding round, which will drive product development and scale production of its fertility-tracking wristband, as well as propel its expansion into European markets.
The Zurich-based company launched the Ava fertility bracelet in the U.S. in July. It is the first device to track the fertile days of a woman’s menstrual cycle in real time, according to the company.
Worn at night, the device continuously records data on nine physiological measures that reflect a rise in hormones associated with ovulation, according to a statement from the company. These measures include pulse, breathing rate, sleep quality and temperature. In the morning, the data is synced with a mobile app. A recent study showed the tracker was able to identify an average of 5.3 fertile days per cycle with 89 percent accuracy.